Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?
- PMID: 28279259
- PMCID: PMC5536951
- DOI: 10.1016/j.ypmed.2016.12.041
Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?
Abstract
The primary goal for many providers in the United States has been to deliver the level of protection against cervical cancer afforded by annual cervical cytology while improving screening test performance. Adoption of recent screening recommendations has been inconsistent and has created considerable consternation and confusion. This editorial addresses the perspective of U.S. patients and providers and how their preferences may run counter to current screening recommendations.
Keywords: Cancer; Cervix; HPV; Screening.
Copyright © 2017 Elsevier Inc. All rights reserved.
References
-
- ACOG. Committee opinion. Recommendations on frequency of Pap test screening Number 152–March 1995 Committee on Gynecologic Practice American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1995 May;49:210–211. - PubMed
-
- ACOG. Practice bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995) ACOG Committee on Practice Bulletins . Obstet Gynecol. 2003 Aug;102(2):417–427. - PubMed
-
- Committee on Practice Bulletins—Gynecology. ACOG practice bulletin number 131: screening for cervical cancer. Obstet Gynecol. 2012 Nov;120:1222–1238. - PubMed
-
- Farrell R, Gebski V, Hacker NF. Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy? Int J Gynecol Cancer. 2014 May;24:813–819. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
